These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4185890)

  • 21. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.
    Lachmann PJ; Kay AB; Thompson RA
    Immunology; 1970 Dec; 19(6):895-9. PubMed ID: 5487541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement mediated inflammatory reactions.
    Kunkel SL; Fantone JC; Ward PA
    Pathobiol Annu; 1981; 11():127-54. PubMed ID: 6173833
    [No Abstract]   [Full Text] [Related]  

  • 23. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.
    Henson PM
    J Immunol; 1971 Dec; 107(6):1535-46. PubMed ID: 5120396
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukotactic factors in health and disease.
    Ward PA
    Am J Pathol; 1971 Sep; 64(3):521-30. PubMed ID: 5133515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of release of constituents from rabbit platelets by antigen-antibody complexes and complement. II. Interaction of platelets with neutrophils.
    Henson PM
    J Immunol; 1970 Aug; 105(2):490-501. PubMed ID: 4393563
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement as a mediator of inflammation in acute gouty arthritis. II. Biological activities generated from complement by the interaction of serum complement and sodium urate crystals.
    Byers PH; Ward PA; Kellermeyer RW; Naff GB
    J Lab Clin Med; 1973 May; 81(5):761-9. PubMed ID: 4698661
    [No Abstract]   [Full Text] [Related]  

  • 27. PARALLEL INHIBITION OF SPONTANEOUS AND ANTIGEN-INDUCED PLATELET HISTAMINE RELEASE.
    SHORE PA; ALPERS HS
    Am J Physiol; 1963 Aug; 205():348-50. PubMed ID: 14058114
    [No Abstract]   [Full Text] [Related]  

  • 28. Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis.
    Ward PA; Hill JH
    J Immunol; 1972 May; 108(5):1137-45. PubMed ID: 4260453
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies on the chemotactic factor of complement and its formation in vivo.
    Ward PA; Cochrane CG; Muller-Eberhard HJ
    Immunology; 1966 Aug; 11(2):141-53. PubMed ID: 4162237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement as a mediator of inflammation: formation of biologically-active products after interaction of serum complement with endotoxins and antigen-antibody complexes.
    Mergenhagen SE
    J Periodontol; 1970 Apr; 41(4):202-4. PubMed ID: 4191699
    [No Abstract]   [Full Text] [Related]  

  • 31. [New findings in complement research].
    Klein P; Hadding U
    Arzneimittelforschung; 1970 Feb; 20(2):167-74. PubMed ID: 4191781
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Kay AB
    Clin Exp Immunol; 1970 Nov; 7(5):723-37. PubMed ID: 4992784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The complement system].
    Lambré C
    Allerg Immunol (Paris); 1993 Sep; 25(7):272, 275-9. PubMed ID: 8216728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil chemotixis mediated by rheumatoid factor.
    Borel JF; Sorkin E; Loewi G
    Immunology; 1971 Jul; 21(1):165-7. PubMed ID: 5105045
    [No Abstract]   [Full Text] [Related]  

  • 35. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.
    Becker EL; Showell HJ; Henson PM; Hsu LS
    J Immunol; 1974 Jun; 112(6):2047-54. PubMed ID: 4596695
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of autoimmune activation of basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of guinea pig C'2 by rabbit antibody. Quantitative measurement of inhibition, discrimination between immune inhibition and complement fixation, specificity of inhibition and demonstration of uptake of C'2 by EAC'1a,4.
    Mayer MM; Miller JA
    Immunochemistry; 1965 Jun; 2(2):71-93. PubMed ID: 4954583
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms underlying inflammatory edema: the importance of synergism between prostaglandins, leukotrienes, and complement-derived peptides.
    Williams TJ; Jose PJ; Wedmore CV; Peck MJ; Forrest MJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():33-7. PubMed ID: 6221544
    [No Abstract]   [Full Text] [Related]  

  • 39. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.
    Ward PA; Hill JH
    J Immunol; 1970 Mar; 104(3):535-43. PubMed ID: 4985169
    [No Abstract]   [Full Text] [Related]  

  • 40. Enzymic activities of Trichophyton rubrum and the chemotaxis of polymorphonuclear leucocytes.
    Davies RR; Zaini F
    Sabouraudia; 1984; 22(3):235-41. PubMed ID: 6379917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.